Zawitz David
Chief Operating Officer
Zawitz David has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Zawitz David is listed as Chief Operating Officer at Verrica Pharmaceuticals Inc. Inside the rolling window, Zawitz David reported 2 open-market purchases totaling $72K in VRCA and no open-market sales. The largest disclosed transaction in the window is a purchase of 10,000 VRCA shares on Nov 25, 2025, worth $42K.
Companies traded
Other insiders at VRCA
Insider Buying
$72K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Zawitz David made?
Zawitz David has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Zawitz David trade?
Zawitz David has filed SEC Form 4 disclosures for 1 company, including VRCA.
When was Zawitz David's most recent SEC Form 4 filing?
Zawitz David's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Zawitz David's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Zawitz David is listed as Chief Operating Officer.
What is Zawitz David's total buy and sell value in the current window?
Inside the rolling retention window, Zawitz David bought $72K and sold $0 based on SEC Form 4 filings.
What was Zawitz David's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 VRCA shares on 2025-11-25, worth $42K, per SEC Form 4 filings.